FDA's regulation of the new drug Versed hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988.

Similar Items

• FDA's regulation of the new drug Versed hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988.
  Published: (1988)
• Oversight of the new drug review process and FDA's regulation of Merital hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986.
  Published: (1987)
• Oversight of the new drug review process and FDA's regulation of Merital hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986.
  Published: (1987)
• FDA's deficient regulation of the new drug Versed seventy-first report
  Published: (1988)
• FDA's drug approval process up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005.
  Published: (2005)